Youngevity International EBIT

The latest EBIT for YGYI is $-34M as of September 2020. That compares with $-28M in the prior-year period — down 21.4% year over year. That is below the Consumer Discretionary sector average of $150B. Investors often review this figure alongside Youngevity International's historical trend and sector peers before judging valuation or financial health.

Over the past year, YGYI's EBIT moved from $-28M to $-34M — a 21.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Youngevity International's operating scale or balance-sheet position.

Against Consumer Discretionary companies, YGYI currently prints $-34M for EBIT, while the sector average sits near $150B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Youngevity International's growth, margins, and balance sheet.

A EBIT figure of $-34M for YGYI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $150B. Explore the charts below for those layers of context.

After noting YGYI's EBIT ($-34M), review year-over-year change from $-28M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.